95% Tax In Drug Pricing Bill Has No Budget Effect, JCT Says
An excise tax of up to 95% on manufacturers who choose not to participate in a drug-pricing negotiation program under legislation proposed by House Democrats would not impact revenue, the Joint...To view the full article, register now.
Already a subscriber? Click here to view full article